The European Commission has granted marketing authorization for Eylea 8mg (aflibercept 8mg, 114.3mg/ml solution for injection ...

Chinese biotech Biyo Pharma says the US regulator has cleared its lead migraine biologic, BY002, to enter clinical trials, ...

Calfornian immunotherapy company ImmunityBio has announced that it has held a Type B End-of-Phase meeting with the US Food and Drug Administration (FDA) regarding the company’s supplemental Biologics ...

South Korean biotech Alteogen (Kosdaq: 196170) has signed an exclusive license agreement with Tesaro, a unit of GSK (LSE: GSK ...

USA-based mRNA vaccines company Moderna’s shares were flat in pre-market activity, as the company announced awaited new ...

California-based biotech BioAge Labs has today announced that it is expanding development of BGE-102, its oral NLRP3 ...

The 11.7% economic interest in specialist HIV company ViiV Healthcare that is currently held by US pharma giant Pfizer is to ...

Danish pharma major Novo Nordisk and privately-held Vancouver-based Aspect Biosystems today announced they are entering a new ...

French vaccine maker Valneva (Euronext Paris: VLA) has abandoned its near-term US plans for its chikungunya vaccine Ixchiq, ...

Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has spent the past decade trying to make the country a more ...

The British Business Bank has made a £50 million ($66.9 million) cornerstone commitment to Epidarex Capital’s next fund. This ...

German biotech Exciva GmbH, which is developing novel therapeutic compounds for the treatment of neuropsychiatric conditions, ...